BENITEC BIOPHARMA INC.
3940 Trust Way
Hayward, California 94545
February 25, 2021
VIA EDGAR
Ada D. Sarmento
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-1004
| Re: | Benitec Biopharma Inc. |
Registration Statement on Form S-3 (File No. 333-253259)
Dear Ms. Sarmento:
Pursuant to Rule 461 of the Securities Act of 1933, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-253259), so that it may become effective at 4:00 p.m. Eastern Time on February 26, 2021, or as soon thereafter as practicable.
[Signature page follows]
| Very truly yours, | ||
| BENITEC BIOPHARMA INC. | ||
| By: | /s/ Dr. Jerel Banks | |
| Name: Dr. Jerel Banks | ||
| Title: Chief Executive Officer | ||
[Signature Page to Acceleration Request]
